Scientists at the Center for Molecular Medicine Cologne (CMMC) and the CECAD Cluster of Excellence on Aging Research have demonstrated in a biomedical study that ribosomes, the protein factories of ...

On 5 August, the US Food and Drug Administration (FDA) granted approval to Moderna’s mRNA-based flu vaccine, mFLUSIVA, for adults aged 50–64, and accelerated approval for adults 65 and older. Moderna ...

Spider-Man Brand New Day science earns expert review from a Cambridge biochemist who confirms the film named siRNA correctly ...

A domestic research team is developing an anticancer technology that attacks DNA mutations found only in cancer cells while ...

Sen. Rick Scott, R-Fla. is speaking out against Dr. Anthony Fauci after texts released Monday revealed he apparently knew there was a risk of miscarriage to women taking the COVID-19 vaccine.

Flusiva is the first FDA-approved seasonal influenza vaccine to use mRNA technology. Beyond influenza itself, how significant is this approval for the future development of vaccines and infectious ...

New research led by the Hudson Institute of Medical Research has shown how a cell recognizes that it is infected with a virus to protect itself and surrounding cells or induce inflammation. The ...

The FDA has approved mFlusiva, the first mRNA-based influenza vaccine, for adults aged 50 years and older, with accelerated approval for those 65 and older.

The four pages of text exchanges, authorized for public release by Republican Sens. Ron Johnson and Rand Paul, involve Dr.

Meghan McCain demanded Dr. Fauci be "put in jail" due to the contents of text messages about the COVID-19 vaccine and ...

Texts obtained from Dr. Anthony Fauci’s phone include a chat between Biden administration officials about pregnant women ...

The vaccine, called mFLUSIVA, is expected to be a versatile new option for people seeking protection from influenza and an important step forward for the widespread adoption of mRNA technology.